uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 04, 2020

Seller of Digestion Supplements Warned for Manufacturing Violations

On January 10, 2020, the FDA issued a warning letter to Marco Pharma International LLC, which found the company's  Absinthium Herbal Liquid Extract 100 ml (Absinthium), promoted for "digestive support", and other products, including S21 Multi Somaplex 100 ml (Multi Somaplex), S9 Molybdenum Somaplex 30 ml (Molybdenum), and S17 Manganese-Copper-Cobalt Somaplex 30 ml (Manganese-Copper-Cobalt) to be adulterated because they were prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at